Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease
- PMID: 26843468
- DOI: 10.1111/hae.12900
Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease
Abstract
Introduction: von Willebrand disease (VWD) is the most common inherited bleeding disorder. The age of bleeding onset is highly variable, also in patients with similar degree of severity.
Aim: The primary aim of this study was to evaluate whether baseline factor VIII (FVIII) plasma levels correlate with age at first bleeding in patients with extremely low levels of VWF:RCo (<6 IU dL(-1) ).
Methods: One hundred and three patients with VWF:RCo <6 IU dL(-1) (6 VWD1, 73 VWD2 and 24 VWD3) undergoing a medical examination between September 2010 and September 2013 were included. The relationship between baseline FVIII levels and age at first bleeding was tested in a multivariable linear regression model, adjusting for sex.
Results: The median age at first bleeding was lower in patients with VWD3 than in those with severe forms of VWD1 or VWD2 (1 year vs. 7 and 8 years, respectively, P < 0.0001). A positive non-linear relationship between FVIII levels and age at first bleeding was found, the latter increasing by 5 years for every 10 IU dL(-1) increase of FVIII (β = 4.95 [95% CI: 2.02-7.87]) until levels of 30 IU dL(-1) , after which the age increased slowly. This relationship was not found in VWD 2A and 2B. In 65 patients (63%) there was a more than 6-month delay between bleeding onset and VWD diagnosis, with no difference over decades.
Conclusions: Baseline FVIII plasma levels influence the age at bleeding onset in VWD patients with extremely low levels of VWF:RCo, except in those with types 2A and 2B.
Keywords: bleeding; blood coagulation disorders; factor VIII; von Willebrand disease; von Willebrand factor.
© 2016 John Wiley & Sons Ltd.
Similar articles
-
Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.Thromb Haemost. 2012 Oct;108(4):683-92. doi: 10.1160/TH12-04-0244. Epub 2012 Aug 23. Thromb Haemost. 2012. PMID: 22918553
-
Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.J Thromb Thrombolysis. 2008 Oct;26(2):150-3. doi: 10.1007/s11239-007-0090-0. Epub 2007 Sep 3. J Thromb Thrombolysis. 2008. PMID: 17786534
-
Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).Blood Coagul Fibrinolysis. 2004 Jun;15(4):323-30. doi: 10.1097/00001721-200406000-00006. Blood Coagul Fibrinolysis. 2004. PMID: 15166918 Clinical Trial.
-
Von Willebrand's disease: case report and review of literature.Pan Afr Med J. 2017 Jun 29;27:147. doi: 10.11604/pamj.2017.27.147.12248. eCollection 2017. Pan Afr Med J. 2017. PMID: 28904675 Free PMC article. Review.
-
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399. Clin Appl Thromb Hemost. 2007. PMID: 17164493 Review.
Cited by
-
Genotype-Phenotype Relationship among 785 Unrelated White Women with Inherited Congenital Factor VII Deficiency: A Three-Center Database Study.J Clin Med. 2023 Dec 21;13(1):49. doi: 10.3390/jcm13010049. J Clin Med. 2023. PMID: 38202056 Free PMC article.
-
Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic Review.J Blood Med. 2023 Mar 2;14:189-208. doi: 10.2147/JBM.S389241. eCollection 2023. J Blood Med. 2023. PMID: 36891166 Free PMC article. Review.
-
Why is Misdiagnosis of von Willebrand Disease Still Prevalent and How Can We Overcome It? A Focus on Clinical Considerations and Recommendations.J Blood Med. 2021 Aug 17;12:755-768. doi: 10.2147/JBM.S266791. eCollection 2021. J Blood Med. 2021. PMID: 34429677 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous